Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
New York Genome Center | RCV001839321 | SCV002099313 | uncertain significance | not provided | 2021-03-26 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004041046 | SCV003747185 | uncertain significance | not specified | 2021-11-09 | criteria provided, single submitter | clinical testing | The c.5144G>A (p.R1715H) alteration is located in exon 13 (coding exon 10) of the MAP2 gene. This alteration results from a G to A substitution at nucleotide position 5144, causing the arginine (R) at amino acid position 1715 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |